Autonomix Medical IncNASDAQ:AMIX
- LAST PRICE3.3200
- TODAY'S CHANGE (%)-0.0400 (-1.1905%)
- Bid / Lots3.3000/ 1
- Ask / Lots3.7500/ 2
- Open / Previous Close3.4500 / 3.3600
- Day Range
- 52 Week Range
- Volume18,180
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | AMIX |
|---|---|---|
| 09:32 ET | 768 | 3.45 |
| 09:34 ET | 1007 | 3.79 |
| 09:36 ET | 503 | 3.75 |
| 09:39 ET | 428 | 3.56 |
| 09:41 ET | 100 | 3.56 |
| 09:43 ET | 1000 | 3.493 |
| 10:03 ET | 224 | 3.4 |
| 10:12 ET | 500 | 3.4 |
| 10:17 ET | 700 | 3.5 |
| 10:26 ET | 250 | 3.4861 |
| 10:39 ET | 375 | 3.42 |
| 11:00 ET | 100 | 3.4944 |
| 11:11 ET | 250 | 3.52 |
| 11:22 ET | 700 | 3.4301 |
| 11:33 ET | 250 | 3.52 |
| 11:36 ET | 200 | 3.52 |
| 12:07 ET | 800 | 3.3801 |
| 12:12 ET | 250 | 3.495 |
| 12:20 ET | 185 | 3.4 |
| 12:21 ET | 300 | 3.38 |
| 12:30 ET | 600 | 3.38 |
| 12:34 ET | 109 | 3.37 |
| 12:48 ET | 100 | 3.36 |
| 01:08 ET | 500 | 3.3601 |
| 01:14 ET | 508 | 3.36 |
| 01:24 ET | 100 | 3.37 |
| 01:37 ET | 400 | 3.3601 |
| 01:42 ET | 200 | 3.38 |
| 02:00 ET | 1600 | 3.3606 |
| 02:54 ET | 300 | 3.37 |
| 02:56 ET | 750 | 3.34 |
| 03:03 ET | 500 | 3.34 |
| 03:07 ET | 360 | 3.37 |
| 03:12 ET | 750 | 3.3655 |
| 03:16 ET | 100 | 3.31 |
| 03:59 ET | 200 | 3.32 |
Apr 25, 2024
Autonomix Enters into Agreement with NoiseFigure Research, Inc. to Develop Next Generation of its Proprietary Microchip, from 8:30AM ET on Thursday Apr 25, 2024 by Dow Jones
8:30AM ET on Thursday Apr 25, 2024 by Dow JonesAutonomix Enters into Agreement with NoiseFigure Research, Inc. to Develop Next Generation of its Proprietary Microchip, from 8:30AM ET on Thursday Apr 25, 2024 by Dow Jones
8:30AM ET on Thursday Apr 25, 2024 by Dow Jones
Apr 24, 2024
Autonomix to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar, from 9:00AM ET on Wednesday Apr 24, 2024 by Dow Jones
9:00AM ET on Wednesday Apr 24, 2024 by Dow JonesAutonomix to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar, from 9:00AM ET on Wednesday Apr 24, 2024 by Dow Jones
9:00AM ET on Wednesday Apr 24, 2024 by Dow Jones
Apr 16, 2024
Autonomix Announces Issuance of U.S. Patent Covering Proprietary Catheter-Based Technology for the Treatment of Cancer Related Pain, from 9:00AM ET on Tuesday Apr 16, 2024 by Dow Jones
9:00AM ET on Tuesday Apr 16, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Autonomix Medical Inc | 63.1M | -6.6x | --- |
Vivos Inc | 58.2M | -19.8x | --- |
Know Labs Inc | 53.4M | -1.8x | --- |
Heartbeam Inc | 52.7M | -2.2x | --- |
Vicarious Surgical Inc | 47.5M | -0.5x | --- |
Movano Inc | 46.7M | -0.7x | --- |
Company Information
Autonomix Medical, Inc. is a medical device company, which is focused on advancing technologies to treat diseases involving the peripheral nervous system. Its technology platform includes a catheter-based microchip sensing array that has the ability to detect and differentiate peripheral neural signals with up to 1,000 times sensitivity. It is developing a two-fold technology that can both detect malfunctioning neural signals and ablate nerves in one simple procedure for pain management. It is developing its technology for pancreatic cancer and pancreatitis, conditions that can cause debilitating pain and need an effective solution. Its technology constitutes a platform with the potential to address dozens of indications, including in cardiology, renal denervation, and chronic pain management across a disease spectrum. Its Autonomix catheter is equipped with a microchip that converts analog signals from the body to a digital signal that can be sent directly to a computer screen.
Contact Information
- Headquarters
- 21 Waterway Ave, Suite 300THE WOODLANDS, TX, United States 77380
- Phone
- 832-277-7816
- Fax
- ---
Executives
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $63.1M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 18.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-0.51 |
Book Value | $0.03 |
P/E Ratio | -6.6x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
